Williamson Douglas J
Transaction: 07/29/2026
OTHER
Change
0
Price
Not reported
Filing
07/31/2026
Type
OTHER
VistaGen Therapeutics, Inc.
VTGN • Biotechnology
$0.24
▼ -0.00 (-1.38%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$10.44M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Healthy liquidity · 3.67Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.24
Change-1.38%
Shares Out42.98M
Market Cap$10.44M
Enterprise Value$-20.51M
52W Range0.20 - 5.14
Beta0.38
P/E-0.15
P/S4.17
P/B0.43
P/FCF-0.17
EV/Sales-8.20
Price$0.24
Change-1.38%
Shares Out42.98M
Market Cap$10.44M
Enterprise Value$-20.51M
52W Range0.20 - 5.14
Beta0.38
P/E-0.15
P/S4.17
P/B0.43
P/FCF-0.17
EV/Sales-8.20
EV/EBITDA0.30
EV/FCF0.33
Earnings Yield-647.98%
FCF Yield-598.16%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-56.84%
Profit Margin-54.91%
Debt/Eq0.03
Current Ratio3.67
Quick Ratio3.67
Target$0.95
Target Upside291.27%
Target Median$0.95
Target Range0.90 - 1.00
Volume891.43K
Avg Volume3.13M
EPS Surprise-0.03
Investment DNA
How strong this company looks for long-term investors
39
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Manageable debt level · 0.03Healthy liquidity · 3.67Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
71/100
Bullish
Bullish
3
Hold
4
Bearish
0
Price Target
2026-08-16
Low
$0.90
Mean
$0.95
Median
$0.95
High
$1.00
Insider Transactions
Recent executive and insider activity
Williamson Douglas J
Transaction: 07/29/2026
BUY
Change
+40,826
Price
$0.24
Filing
07/31/2026
Type
BUY
Singh Shawn
Transaction: 06/30/2026
BUY
Change
+36,818
Price
$0.19
Filing
07/02/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Williamson Douglas J | OTHER | 0 | Not reported | 07/29/2026 | 07/31/2026 |
| Williamson Douglas J | BUY | +40,826 | $0.24 | 07/29/2026 | 07/31/2026 |
| Singh Shawn | BUY | +36,818 | $0.19 | 06/30/2026 | 07/02/2026 |
| Tressler Nick B. | BUY | +11,712 | $0.19 | 06/30/2026 | 07/02/2026 |
| Adler Reid G. | BUY | +36,818 | $0.19 | 06/30/2026 | 07/02/2026 |
| Angelov Angel S | OTHER | 0 | Not reported | 05/18/2026 | 05/19/2026 |
| Angelov Angel S | BUY | +150,000 | $0.60 | 05/18/2026 | 05/19/2026 |
| Adler Reid G. | BUY | +18,753 | $0.54 | 04/07/2026 | 04/09/2026 |
| Adler Reid G. | BUY | +56,247 | $0.54 | 04/07/2026 | 04/09/2026 |
| Cote Elissa S. | BUY | +75,000 | $0.54 | 04/07/2026 | 04/09/2026 |
| Prince Joshua S. | BUY | +18,752 | $0.54 | 04/07/2026 | 04/09/2026 |
| Prince Joshua S. | BUY | +56,248 | $0.54 | 04/07/2026 | 04/09/2026 |
| Singh Shawn | BUY | +3,732 | $0.54 | 04/07/2026 | 04/09/2026 |
| Singh Shawn | BUY | +71,268 | $0.54 | 04/07/2026 | 04/09/2026 |
| Tressler Nick B. | BUY | +75,000 | $0.54 | 04/07/2026 | 04/09/2026 |
| Prince Joshua S. | BUY | +4,386 | $0.56 | 12/31/2025 | 01/05/2026 |
| Tressler Nick B. | OTHER | 0 | Not reported | 12/01/2025 | 12/04/2025 |
| Tressler Nick B. | BUY | +150,000 | $4.43 | 12/01/2025 | 12/04/2025 |
| Edick Paul R | OTHER | 0 | Not reported | 10/27/2025 | 11/04/2025 |
| Edick Paul R | BUY | +35,200 | $3.90 | 10/27/2025 | 11/04/2025 |